FREE patent keyword monitoring and additional FREE benefits. http://images1.freshpatents.com/images/triangleright (1K) REGISTER now for FREE triangleleft (1K)
FreshPatents.com Logo    FreshPatents.com icons
Monitor Keywords Patent Organizer File a Provisional Patent Browse Inventors Browse Industry Browse Agents


Drug, Bio-affecting And Body Treating Compositions > Preparations Characterized By Special Physical Form

Preparations Characterized By Special Physical Form

Preparations Characterized By Special Physical Form patent applications listed include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.

04/17/14 - 20140105936 - Pharmaceutical composition for the preparation of infusion solutions of antimicrobial preparations, its production process (variations)
The proposed compositions and methods for preparation thereof relate to pharmacology, medicine, veterinary science and pharmaceutical industry. The compositions can be used for preparing infusion solutions of antimicrobial (antibacterial and antifungal) preparations increasing therapeutic efficiency thereof. The compositions include nanostructured colloidal silica and are efficient when treating overwhelming sepsis of...

04/17/14 - 20140105937 - Topical ubiquinol oral supplement compositions with amorphous calcium phosphate
Topical, UBIQUINOL, adjunctive, supplement compositions, containing amorphous calcium phosphate fluoride (ACPF), useful in: reducing oxidative stress, relieving oral discomfort and dry mouth, and remineralizing hydroxyapatite; comprising: UBIQUINOL in an aqueous-free emulsion that also contains: a stabilizing composition for UBIQUINOL, spilanthes extract, a trans-oral mucosal, absorption facilitator and ACPF; wherein: the...

04/17/14 - 20140105938 - Cartilage cell processing system
An automated or semi-automated module-based cartilage cell processing device (20) for preparing a cell seeded carrier (27a) from a biological material, comprising at least a cartilage preparation module (21), a cell isolation module (22), a cell mixing module (29) and a carrier cell seeding module (29a). The invention further relates...

04/17/14 - 20140105939 - Methods and compositions for modulating myofibroblast activities
The present invention discloses methods and compositions for treating or ameliorating a condition associated with increased or decreased myofibroblast activities and use thereof...

04/17/14 - 20140105940 - Biocompatible material and uses thereof
The present invention relates to a biocompatible material and in particular to a two-phase or composite biocompatible ceramic material, wherein the first phase is a doped calcium zinc silicate and the second phase is a metal oxide. In an embodiment, the invention has been developed for use in tissue regeneration...

04/10/14 - 20140099342 - Botulinum nanoemulsions
The embodiment described herein are related nanoemulsions comprising botulinum toxins. In one embodiment, the nanoemulsions are prepared by high pressure microfluidization and comprise a particle size distribution exclusively between 10 and 300 nm. The nanoemulsions contemplated by the present invention are useful for the cosmetic and medical treatment of muscular...

04/10/14 - 20140099343 - Ophthalmic device, and method of use thereof, for increasing ocular boundary lubrication
The present invention provides an ophthalmic device, and method of use thereof, for an individual wearing an ophthalmic lens to increase ocular surface boundary lubrication. The invention device comprises an ophthalmic lens and a sacrificial mechanism disposed on the ophthalmic lens, wherein the sacrificial mechanism comprises a plurality of surface...

04/10/14 - 20140099344 - Process for dispersing amino acids
A coated proteinaceous material can be produced by contacting the proteinaceous material with de-oiled phospholipids or mixtures thereof containing less than 20% triglycerides. The coating has between 0.1 and 1.5% by weight of the total proteinaceous material, of de-oiled lecithin. The proteinaceous material is hydrophobic, especially amino acids having a...

04/10/14 - 20140099345 - Omega-3 diglyceride emulsions
The present invention relates to omega-3 diglyceride emulsions characterized in that the lipid phase comprises at least about 40 wt.-% of diglycerides. Preferably about 70 wt.-% of the acyl-groups of said diglycerides are eicoapentaenoic acid (EPA) groups and/or docasahexaenoic (DHA) groups. The invention further relates to methods of treatment using...

04/03/14 - 20140093543 - Method and vacuum container for preparing a bone graft
A vacuum container supports a cancellous device fully immersed within a solution of a bone growth promoting substance in a sealed chamber. The solution may include one of a Demineralized Bone Matrix (DBM) solution, a morphegenic protein solution, or a stem cell solution. A vacuum creating device is in fluid...

04/03/14 - 20140093544 - Solid oral sensorial products including stain inhibitor
A solid oral sensorial product includes at least one botanical material and at least one phosphate containing stain inhibitor. The botanical material is selected from the group consisting of tobacco, tea, coffee, cocoa, and combinations thereof....

04/03/14 - 20140093545 - Antibacterial pharmaceutical preparation
The present invention refers to a pharmaceutical preparation for use as an antibacterial agent, where the pharmaceutical preparation is prepared by a method comprising the steps of bringing a full blood sample taken from a patient in contact with a vessel or container and incubating the sample....

04/03/14 - 20140093546 - Implants for administering substances and methods of producing implants
A porous silicon implant impregnated with a beneficial substance, such as a micromineral required for healthy physiology, is implanted subcutaneously and is entirely corroded away over the following months/year to release the beneficial substance in a controlled manner. In a second embodiment the implant may have a large number of...

03/27/14 - 20140086962 - Products of manufacture having tantalum coated nanostructures, and methods of making and using them
In alternative embodiments, the invention provides products (articles) of manufacture comprising nanostructures such as nanotubes having a surface comprising tantalum. In alternative embodiments, products of manufacture of the invention include nanostructures, e.g., nanotubes, nanowire, nanopore, and the like comprising a surface layer of tantalum. In alternative embodiments, products or articles...

03/27/14 - 20140086963 - Methods of wound care and treatment
Particular embodiments disclosed herein relate to gas-enriched fluids, methods of making the same, systems for making the same and/or methods of treatment utilizing the gas-enriched fluids for wound care related conditions and/or diseases. In certain embodiments, the gas-enriched fluid is oxygen-enriched water. Certain embodiments relate to cosmetic and/or therapeutic fluids...

03/20/14 - 20140079739 - Derivation of fibrochondrocytes from progenitor cells
Provided herein are compositions and methods for forming fibrochondrocytes or fibrochondrocyte-like cells from progenitor cells, such as mesenchymal stem cells. One aspect provides a fibrochondrocyte culture medium including CTGF and TGFβ3, optionally encapsulated by microspheres having different release profiles. Another aspect provides a method for forming fibrochondrocytes or fibrochondrocyte-like cells...

03/20/14 - 20140079740 - Oral transmucosal adminstration forms of s-ketamine
The present invention relates to methods and compositions for the treatment of pain, in a preferred embodiment relating to the oral transmucosal administration of S-Ketamine, its salts or derivatives....

03/20/14 - 20140079741 - Inhibition and treatment of biofilms
Treatment of a fungal biofilm on implants is via a combination of drugs and/or via the implant pre-treatment with one drug or via the combination of drugs....

03/20/14 - 20140079742 - Coating of fast absorption or dissolution
A coating of fast absorption or fast dissolution on an implantable device and methods of making and using of the coating are provided....

03/20/14 - 20140079743 - Coatings of acrylamide-based copolymers
An implantable device including a conjugate formed of an acrylamide-based copolymer and a bioactive agent is provided....

03/13/14 - 20140072599 - Cytokine-producing cell sheet and method for using the same
The types and relative proportions of cells constituting a cell sheet stack, and the number of cells to be seeded are altered to change the state of the cells in the cell sheet stack, whereby production of an angiogenesis-promoting cytokine as well as construction of a vascular endothelial network can...

03/13/14 - 20140072600 - Factor xii inhibitors for the administration with medical procedures comprising contact with artificial surfaces
An inhibitor of FXII/FXIIa for the prevention of the formation and/or stabilization of thrombi during and/or after a medical procedure performed on a human or animal subject comprising contacting blood of said human or animal subject with artificial surfaces, wherein said inhibitor of FXII/FXIIa is administered before and/or during and/or...

03/13/14 - 20140072601 - Transport of cells in hydrogels
The present invention relates to hydrogels which may be used to encapsulate or entrap live cells. The invention further relates to methods for transporting live cells which are encapsulated or entrapped within hydrogels from a first location to a second location. The invention further relates to method of treating a...

03/13/14 - 20140072602 - Micelle encapsulation of a combination of therapeutic agents
The invention provides active agents, such as paclitaxel, rapamycin, or 17-DMAG, encapsulated by safe poly(ethylene glycol)-block-poly(lactic acid) (“PEG-b-PLA”) micelles. The compositions provide effective solubilization of drug combinations, such as paclitaxel, rapamycin, and 17-DMAG, as well as others described herein. A significant advantage of PEG-b-PLA as a carrier is that it...

03/13/14 - 20140072603 - Immunomodulatory materials for implantable medical devices
The present invention relates to biomaterials that interact with and regulate immune functions, as well as implantable materials and devices. In one embodiment, the present invention provides an implantable medical device comprising a biomaterial coated with one or more CD200 molecules. In another embodiment, the present invention provides a method...

03/13/14 - 20140072604 - Block copolymer for intraperitoneal administration containing anti-cancer agent, micelle preparation thereof, and cancer therapeutic agent comprising the micelle preparation as active ingredient
A therapeutic agent as a micelle preparation, comprising a copolymer having a hydrophilic polymeric moiety and a polycarboxylic acid derivative moiety; and an anti-cancer agent bonding to or encapsulated in the copolymer, wherein the micelle preparation may exhibit sustained drug release capability, and enables an extension of a retention time...

03/13/14 - 20140072605 - Substrates for drug delivery device and methods of preparing and use
An assembly and method for producing a condensation aerosol are disclosed. The assembly includes a heat-conductive metal substrate with an oxidation resistant exterior surface and a drug composition film on the exterior surface and is for use in an aerosol device. The thickness of the film and the surface of...

03/06/14 - 20140065191 - Topical pharmaceutical composition comprising nanonized silver sulfadiazine
The invention relates to a topical pharmaceutical composition for burn treatment and microbial infections on human beings or animals. The pharmaceutical composition comprises 0.1% w/w to 1.0% w/w of an antimicrobial drug, i.e., silver sulfadiazine and 0.2% w/w antiseptic, i.e., chlorhexidine gluconate, wherein silver sulfadiazine is in nanonized form....

03/06/14 - 20140065192 - Sour gelled emulsions
The invention relates to an orally administrable, sour-tasting chewable composition in unit dosage form comprising an oil-in-water emulsion in which the aqueous phase is gelled and comprises at least one physiologically acceptable acid and at least one buffering agent and in which the oil phase comprises a physiologically tolerable unsaturated...

03/06/14 - 20140065193 - Zscan4 as a marker for pancreatic stem cells and progenitor cells and use thereof
ZSCAN4, a gene expressed in ES cells and 2-cell stage embryos, has been previously shown to regulate telomere elongation and genome stability in mouse ES cells. It is disclosed herein that in the adult human pancreas, a small number of ZSCAN4-positive cells are present among cells located in the islets...

03/06/14 - 20140065194 - Three-dimensional printing system and equipment assembly
A three-dimensional printing system and equipment assembly for the manufacture of three-dimensionally printed articles is provided. The equipment assembly includes a three-dimensional printing build system, an optional liquid removal system and an optional harvester system. The build system includes a conveyor, plural build modules and at least one build station...

03/06/14 - 20140065195 - Ureaplasma vaccine and antibody for prevention and treatment of human, animal and cell culture infection
The present invention encompasses methods and compositions for Ureaplasma infection prevention and/or treatment. In specific cases, the invention concerns vaccines for Ureaplasma, including DNA vaccines. In certain embodiments, the invention regards vaccines directed towards the multiple-banded antigen(s) of Ureaplasma....

02/27/14 - 20140056947 - Virus traps
Specific applications of particles and particle agglomerates with semiconductor surfaces are provided. The particles and particle agglomerates display a high affinity for viral particles, and may be used therapeutically and/or prophylactically to treat or prevent viral infections. The particles and particle agglomerates may also be used to remove viral particles...

02/27/14 - 20140056948 - Hard tissue regeneration material and method for manufacturing the same
A hard tissue regeneration material and a method for manufacturing the same are disclosed. The hard tissue regeneration material of the present invention comprises: ZnO particles selected from the group consisting of crystallized ZnO particles, crystallized ZnO nanorods, nano-ZnO hollow fibers, and a combination thereof; and at least one selected...

02/27/14 - 20140056949 - Controlled release mucoadhesive systems
Formulations for chemoprevention of oral cancer and precancerous lesions, and for methods for preparing the formulations are described....

02/27/14 - 20140056950 - Tricalcium phosphates, their composites, implants incorporating them, and methods for their production
Methods for the synthesis of tricalcium phosphates are presented, as well as a series of specific reaction parameters that can be adjusted to tailor, in specific ways, properties in the tricalcium phosphate precursor precipitate. Particulate tricalcium phosphate compositions having an average crystal size of about 250 nm or less are...

02/27/14 - 20140056951 - Methods and compositions for treating biofilms
Methods of treating or reducing biofilms, treating a biofilm-related disorder, and preventing biofilm formation using polyamines is described....

02/27/14 - 20140056952 - Methods and coatings for treating biofilms
Methods of treating or reducing biofilms, treating a biofilm-related disorder, and preventing biofilm formation using polyamines is described....

02/27/14 - 20140056953 - Fatty acid acylated amino acids for oral peptide delivery
The present invention relates to fatty acid acylated amino acids (FA-aa's) acting as permeation enhancers for oral delivery of therapeutic macromolecules such as peptides and pharmaceutical compositions comprising such FA-aa's....

02/20/14 - 20140050765 - Devices and methods for tissue engineering
A resorbable tissue scaffold in a glass ceramic composition forms a rigid three-dimensional porous matrix having a bioactive composition. Porosity in the form of interconnected pore space is provided by the space between the glass-ceramic fiber forming the porous matrix. Strength of the porous matrix is provided by the interconnected...

02/20/14 - 20140050766 - Tissue engineering construct comprising fibrin
A three-dimensional fibrin engineered tissue construct is provided selected from: (i) a fibrin gel matrix comprising a combination of tissue-specific cells and at least one type of vascular cells; and (ii) a hybrid scaffold of fibrin gel and a polymeric synthetic scaffold comprising at least one type of vascular cells...

02/13/14 - 20140044753 - Composition containing inorganic nanoparticles as an active ingredient for preventing or treating of angiogenesis-related diseases
Provided is a pharmaceutical composition containing inorganic nanoparticles selected from titanium oxide nanoparticles or silica nanoparticles as an active ingredient for preventing or treating angiogenesis-related diseases. The pharmaceutical composition for preventing or treating angiogenesis-related diseases according to the present invention may be used as a therapeutic agent for various diseases...

02/13/14 - 20140044754 - Tdf-related compounds and analogs thereof
The present invention relates generally to tissue differentiation factor (TDF) analogs. More specifically, the invention relates to structure-based methods and compositions useful in designing, identifying, and producing molecules which act as functional modulators of TDF-like receptors. The invention further relates to methods of detecting, preventing, and treating TDF-associated disorders....

02/13/14 - 20140044755 - Rnai pharmaceutical composition for suppressing expression of kras gene
R3 is a hydrogen atom, alkyl having a carbon number of from 1 to 6, or alkenyl having a carbon number of from 3 to 6, and the like....

02/13/14 - 20140044756 - Multilayer nanofiber filter
A method of making a multilayer filter and the multilayer filter made by the method. The method includes generally two steps. The first step is to coat a layer of nanofibers on a single side or both sides of a substrate medium to obtain a composite filter medium, and the...

02/13/14 - 20140044757 - Method for selectively inhibiting acat1 in the treatment of alzheimer's disease
The present invention features methods for stimulating clearance of amyloid beta in microglia, decreasing cognitive decline associated with amyloid pathology, and treating Alzheimer's disease by selectively inhibiting the expression or activity of Acyl-CoA:Cholesterol Acyltransferase 1, but not Acyl-CoA:Cholesterol Acyltransferase 2....

02/13/14 - 20140044758 - Wound dressing with bacteriostasis and hygroscopicity
A wound dressing with bacteriostatic and hygroscopicity, preparation method therefore, and the use thereof in preparing a product for treating chronic wounds. The dressing comprises chitosan fiber and modified cellulose fiber....

02/13/14 - 20140044759 - Drug substances, pharmaceutical compositions and methods for preparing the same
Drug substances, which comprise a solid amorphous forms of a compound of structural formula I and have a BET specific surface area of up to about 94 m2/g, pharmaceutical compositions comprising such drug substances, processes for preparing such drug substances and uses of such drug substances and pharmaceutical compositions are...

02/06/14 - 20140037696 - Synthetic cell platforms and methods of use thereof
The present invention provides synthetic cell platforms. The synthetic cell platforms can be used for culturing cells in vitro. The synthetic cell platforms can also be implanted together with bound cells into an individual. The present invention provides methods of using the platforms to provide cells or progeny of such...

02/06/14 - 20140037697 - Particulate materials
Embodiments of the invention relate to particles of active substances, methods for preparing the particles, formulations containing the particles, and metered dose inhalers containing such particles or formulations. In one embodiment, a composition of an aerosol formulation is provided and contains a particulate active substance of non-micronized, solid particles having...

02/06/14 - 20140037698 - Additives for animal food
The present invention relates to the combination of organic acid salts with at least one active ingredient of plant origin, preferably essential oils, partially protected with vegetable fats and/or oils, which prevent these active ingredients from being digested by stomach enzymes during the digestive process. The sodium salts of short-chain...

02/06/14 - 20140037699 - Soluble non-depot insulin conjugates and uses thereof
In one aspect, the disclosure provides a conjugate comprising an insulin molecule having an A-chain and a B-chain; an affinity ligand covalently bound to the A-chain; and a monovalent glucose binding agent covalently bound to the B-chain, wherein the affinity ligand competes with glucose for non-covalent binding with the monovalent...

02/06/14 - 20140037700 - Composition and method for enhancing an immune response
Disclosed are methods and compositions for treating or preventing microbial infections....